|
|
|
|
Bone Marrow Transplant Procedures News
|
|
|
|
|
|
|
All Recent Bone Marrow Transplant Procedures News |
|
|
|
|
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML
Authors: F L Locke, A Artz, E Rich, Y Zhang, K van Besien
& W Stock (Source: Bone Marrow Transplantation)...
POSTED 03/07/2010 at 06:00 PM --
|
Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD
Authors: T Schechter, C Macartney, Y Finkelstein, A Gassas, M Husain, J Doyle
& L L Dupuis (Source: Bone Marrow Transplantation)...
POSTED 03/07/2010 at 06:00 PM --
|
Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT
Authors: K Ueda, T Watadani, E Maeda, S Ota, K Kataoka, S Seo, K Kumano, A Hangaishi, T Takahashi, Y Imai, K Ohtomo, M Fukayama, Y Nannya
& M Kurokawa (Source: Bone Marrow Transplantation)...
POSTED 03/07/2010 at 06:00 PM --
|
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
Bone Marrow Transplantation advance online publication, March 8, 2010. doi:10.1038/bmt.2010.49
Authors: S G Holtan, W J Hogan, M A Elliott, S M Ansell, D J Inwards, L F Porrata, P B Johnston, I N Micallef, M Q Lacy, D A Gastineau
& M R Litzow (Source: Bone Marrow Transplantation)...
POSTED 03/07/2010 at 06:00 PM --
|
Hemorrhagic Cystitis and Possible Neurologic Disease from BK Virus Infection in a Patient with AIDS
We present a rare case of BKV-associated hemorrhagic cystitis in a 48-year-old man with AIDS and previously diagnosed
progressive multifocal leukoencephalopathy.
Content Type Journal ArticleCategory Case ReportDOI 10.1007/s15010-009-9201-5Authors
A. N. Kinnaird, University of Texas Health Science Center at San Antonio Dept. of Medicine San Antonio TX USAG. M. Anstead, South Texas Veterans Healthcare System Dept. of Medicine, Division of Infectious Diseases San Antonio TX USA
Journal InfectionOnline ISSN 1439-0973Print ISSN 0300-8126 (Source: Infection)...
POSTED 03/03/2010 at 02:52 AM --
|
Drug cuts bone marrow nausea, vomiting
ORLANDO, Fla., March 3 (UPI) -- A drug can dramatically reduce both nausea and vomiting when combined with other anti-nausea drugs in bone marrow transplant patients, U.S. researchers say. (Source: Health News - UPI.com)...
POSTED 03/02/2010 at 11:36 PM --
|
Nausea And Vomiting Dramatically Reduced In Bone Marrow Transplant Patients
Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation. But a Loyola University Health System study has found the drug aprepitant can dramatically reduce both nausea and vomiting when combined with other anti-nausea drugs... (Source: GastroIntestinal News From Medical News Today)...
POSTED 03/02/2010 at 05:00 AM --
|
Nausea And Vomiting Dramatically Reduced In Bone Marrow Transplant Patients
Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation. But a Loyola University Health System study has found the drug aprepitant can dramatically reduce both nausea and vomiting when combined with other anti-nausea drugs. Seventy-three percent of patients receiving aprepitant experienced no vomiting during the study period, compared with 23 percent of patients who received a placebo. (Both groups also received a standard anti-nausea drug... (Source: Health News from Medical News Today)...
POSTED 03/02/2010 at 05:00 AM --
|
The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation
Bone Marrow Transplantation advance online publication, March 1, 2010. doi:10.1038/bmt.2010.10
Author: E W Petersdorf (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
International exchange of cord blood units: the registry aspects
Authors: K Welte, L Foeken, E Gluckman
& C Navarrete (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset
Authors: J H Moon, S N Kim, B W Kang, Y S Chae, J G Kim, J S Ahn, Y K Kim, D H Yang, J J Lee, H J Kim, Y J Choi, H J Shin, J S Chung, G J Cho
& S K Sohn (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse
Authors: S Thiant, I Yakoub-Agha, L Magro, J Trauet, V Coiteux, J-P Jouet, J-P Dessaint
& M Labalette (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products
Authors: M Maiers, J N A Bakker, W Bochtler, H-P Eberhard, S G E Marsh, C Müller
& H-G Rist (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Successful engraftment of a second transplant from unrelated cord blood identifying acceptable HLA Ag mismatches as treatment for primary graft failure possibly mediated by anti-HLA Abs after ‘mega-dose’ haploidentical PBSC transplantation
Successful engraftment of a second transplant from unrelated cord blood identifying acceptable HLA Ag mismatches as treatment for primary graft failure possibly mediated by anti-HLA Abs after ‘mega-dose’ haploidentical PBSC transplantation
Bone Marrow Transplantation advance online publication, March 1, 2010. doi:10.1038/bmt.2010.30
Authors: T Hoshino, T Sakura, K Miyawaki, N Hatsumi, S Takada, E Maruya, H Saji
& S Miyawaki (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs
Authors: S C Kussmaul, B N Horn, C C Dvorak, L Abramovitz, M J Cowan
& P S Weintrub (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy
Authors: L Fianchi, C Colosimo, A De Luca, A Pompucci, P Cattani, M T Voso, L M LaRocca, G Leone
& L Pagano (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency
Authors: S M Reddy, D J Winston, M C Territo
& G J Schiller (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Prognostic impact of serum ferritin concentration on survival following reduced-intensity conditioned allogeneic haemopoietic SCT
Authors: R Oakes, Nitin Sood, R Pearce, D Swirsky, G Cook
& M Gilleece (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Unrelated hematopoietic stem cell donors as research subjects
Authors: R J King, D L Confer, H T Greinix, J Halter, M Horowitz, A H Schmidt, P Costeas, B Shaw
& T Egeland (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
Authors: O Blennow, M Remberger, L Klingspor, B Omazic, K Fransson, P Ljungman, J Mattsson
& O Ringdén (Source: Bone Marrow Transplantation)...
POSTED 02/28/2010 at 06:00 PM --
|
|
|
|
|
|
 |
|
|
|
|
|
IMPORTANT NOTICE:
The information provided on this site is intended for your general knowledge only and is not a substitute for professional
medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a
qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
|
|
|
|
|
|
|
|
Featured Product! |
 |
|
Total Balance
Men's Plus |
|
"The restoration and maintenance of normal organ and brain function, a strong immune system, and the balancing of hormones is the key to vibrant health and in avoiding premature-aging!" |
|
CLICK HERE
for more info... |
|
|
